Valuation: Bayer AG

Market Cap 4.85TCr 5.59TCr 4.54TCr 4.16TCr 7.85TCr 5,32700Cr 7.95TCr 53TCr 21TCr 2,66200Cr 21TCr 21TCr 8,85900Cr P/E 2026 *
21x
P/E 2027 * 16.1x
Enterprise Value 7.77TCr 8.96TCr 7.28TCr 6.66TCr 13TCr 8,53300Cr 13TCr 85TCr 33TCr 4,26400Cr 34TCr 33TCr 14,19100Cr EV / Sales 2026 *
1.7x
EV / Sales 2027 * 1.62x
Free-Float
100%
Yield 2026 *
0.32%
Yield 2027 * 1.07%
1 week+2.59%
Current month+2.59%
1 month-5.56%
3 months+32.16%
6 months+13.97%
Current year+39.10%
1 week 205
Extreme 205
214.1
1 month 205
Extreme 205
223.1
3 years 78.97
Extreme 78.97
241
Manager TitleAgeSince
Chief Executive Officer 60 01/06/2023
Director of Finance/CFO 57 01/06/2026
Chief Tech/Sci/R&D Officer 59 01/02/2021
Director TitleAgeSince
Director/Board Member 56 01/04/2012
Director/Board Member 60 01/04/2017
Chairman 68 28/04/2020
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+2.59%+94.35%-8.58% 5.59TCr
-0.13%+3.62%+85.76%+162.16% 1,06200Cr
-0.10%+0.39%+50.03%+48.67% 62TCr
+0.16%-2.24%+23.36%+63.19% 43TCr
+1.29%+5.06%+49.14%+40.27% 36TCr
+0.86%+0.03%+36.10%+40.95% 29TCr
+0.89%-5.03%+9.56%+10.21% 25TCr
+0.43%+5.90%+43.27%+61.26% 22TCr
+4.44%-0.49%-1.25%-44.11% 20TCr
+1.39%+1.98%+20.41%+64.60% 16TCr
Average +1.05%-1.90%+41.07%+43.86% 39.91TCr
Weighted average by Cap. +0.59%-0.83%+49.48%+74.88%

Financials

2026 *2027 *
Net sales 4.57TCr 5.27TCr 4.28TCr 3.92TCr 7.39TCr 5,01900Cr 7.49TCr 50TCr 20TCr 2,50800Cr 20TCr 19TCr 8,34600Cr 4.69TCr 5.41TCr 4.4TCr 4.02TCr 7.59TCr 5,15300Cr 7.69TCr 51TCr 20TCr 2,57500Cr 20TCr 20TCr 8,57000Cr
Net income 216.76Cr 249.78Cr 202.97Cr 185.67Cr 350.51Cr 24TCr 355.09Cr 2.37TCr 931.88Cr 12TCr 937.83Cr 917.45Cr 40TCr 291.54Cr 335.95Cr 272.99Cr 249.72Cr 471.43Cr 32TCr 477.58Cr 3.19TCr 1.25TCr 16TCr 1.26TCr 1.23TCr 53TCr
Net Debt 2.92TCr 3.37TCr 2.73TCr 2.5TCr 4.72TCr 3,20600Cr 4.78TCr 32TCr 13TCr 1,60200Cr 13TCr 12TCr 5,33200Cr 2.73TCr 3.15TCr 2.56TCr 2.34TCr 4.42TCr 3,00100Cr 4.48TCr 30TCr 12TCr 1,50000Cr 12TCr 12TCr 4,99100Cr
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
-
Date Price Change
07/26/07 PLN 214.10 0.00%
06/26/06 PLN 214.10 0.00%
05/26/05 PLN 214.10 +1.71%
04/26/04 PLN 210.50 +2.68%
03/26/03 PLN 205.00 -1.77%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
49.40EUR
Average target price
56.81EUR
Spread / Average Target
+14.99%

Quarterly revenue - Rate of surprise